title: Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Internal Medicine I, University of Köln, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Eichhorst
authors.forename: M
authors.initials: M
authors.lastname: Hallek
authors.forename: M
authors.initials: M
authors.lastname: Dreyling
mesh_terms: D018941:Antigens, CD19 / Q000378:metabolism; D018951:Antigens, CD20 / Q000378:metabolism; D018956:CD5 Antigens / Q000378:metabolism; D004358:Drug Therapy; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D017404:In Situ Hybridization, Fluorescence; D015994:Incidence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D017455:Receptors, IgE / Q000378:metabolism; D018570:Risk Assessment; D055502:Secondary Prevention; D033581:Stem Cell Transplantation; D016896:Treatment Outcome
chemical_list: D018941:Antigens, CD19; D018951:Antigens, CD20; D018956:CD5 Antigens; D017455:Receptors, IgE